Gupta N, Gupta R, Acharya AK, Patthi B, Goud V, Reddy S, Garg A, Singla A. Changing trends in oral cancer-a global scenario. Nepal J Epidemiol. 2016;6(4):613.
Article PubMed PubMed Central Google Scholar
Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884.
CAS PubMed PubMed Central Google Scholar
Marcazzan S, Varoni EM, Blanco E, Lodi G, Ferrari M. Nanomedicine, an emerging therapeutic strategy for oral cancer therapy. Oral Oncol. 2018;76:1–7.
Article CAS PubMed Google Scholar
Saini R, Lee NV, Liu KY, Poh CF. Prospects in the application of photodynamic therapy in oral cancer and premalignant lesions. Cancers. 2016;8(9):83.
Article PubMed PubMed Central Google Scholar
Pellosi DS, De Jesus PD, Tedesco AC. Spotlight on the delivery of photosensitizers: different approaches for photodynamic-based therapies. Expert Opin Drug Deliv. 2017;14(12):1395–406.
Article CAS PubMed Google Scholar
Shen L, Huang Y, Chen D, Qiu F, Ma C, Jin X, Zhu X, Zhou G, Zhang Z. pH-responsive aerobic nanoparticles for effective photodynamic therapy. Theranostics. 2017;7(18):4537.
Article CAS PubMed PubMed Central Google Scholar
Chang MH, Pai CL, Chen YC, Yu HP, Hsu CY, Lai PS. Enhanced antitumor effects of epidermal growth factor receptor targetable cetuximab-conjugated polymeric micelles for photodynamic therapy. Nanomaterials. 2018;8(2):121.
Article PubMed PubMed Central Google Scholar
Chen K, Preuß A, Hackbarth S, Wacker M, Langer K, Röder B. Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations. J Photochem Photobiol B. 2009;96(1):66–74.
Article CAS PubMed Google Scholar
Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 2008;26(11):612–21.
Article CAS PubMed Google Scholar
Lee SJ, Koo H, Lee DE, Min S, Lee S, Chen X, et al. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials. 2011;32:4021e9.
Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev. 1995;24(1):19–33.
Lukyanov AN, Torchilin VP. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev. 2004;56(9):1273–89.
Article CAS PubMed Google Scholar
Hamblin MR, Miller JL, Rizvi I, Ortel B, Maytin EV, Hasan T. Pegylation of a chlorin e6 polymer conjugate increases tumor targeting of photosensitizer. Cancer Res. 2001;61(19):7155–62.
Wang M, Lu P, Wu B, Tucker JD, Cloer C, Lu Q. High efficiency and low toxicity of polyethyleneimine modified Pluronics (PEI–Pluronic) as gene delivery carriers in cell culture and dystrophic mdx mice. J Mater Chem. 2012;22(13):6038–46.
Alakhov V, Lemieux P, Klinski E, Kabanov A, Pietrzynski G. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opin Biol Ther. 2001;1(4):583–602.
Article CAS PubMed Google Scholar
Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br J Cancer. 2001;85(12):1987–97.
Article CAS PubMed PubMed Central Google Scholar
Batrakova EV, Li S, Brynskikh AM, Sharma AK, Li Y, Boska M, Gong N, Mosley RL, Alakhov VY, Gendelman HE, Kabanov AV. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release. 2010;143(3):290–301.
Article CAS PubMed PubMed Central Google Scholar
Batrakova EV, Han HY, Alakhov VY, Miller DW, Kabanov AV. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm Res. 1998;15:850–5.
Article CAS PubMed Google Scholar
Kumari P, Jain S, Ghosh B, Zorin V, Biswas S. Polylactide-based block copolymeric micelles loaded with chlorin e6 for photodynamic therapy: in vitro evaluation in monolayer and 3D spheroid models. Mol Pharm. 2017;14(11):3789–800.
Article CAS PubMed Google Scholar
Vysyaraju NR, Paul M, Ch S, Ghosh B, Biswas S. Olaparib@ human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer. J Drug Target. 2022;30(10):1088–105.
Das S, Paul M, Ghosh B, Biswas S. Synergistic anticancer response via docetaxel-and oleanolic acid-loaded albumin/poly (lactide) nanoparticles in triple-negative breast cancer. ACS Appl Nano Mater. 2023;6(21):19710–26.
Itoo AM, Paul M, Ghosh B, Biswas S. Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer. Biomaterials Adv. 2023;153:213550.
Paul M, Itoo AM, Ghosh B, Biswas S. Hypoxia alleviating platinum (IV)/chlorin e6-based combination chemotherapeutic-photodynamic nanomedicine for oropharyngeal carcinoma. J Photochem Photobiol B. 2023;238:112627.
Article CAS PubMed Google Scholar
Jain R, Paul M, Padaga SG, Dubey SK, Biswas S, Singhvi G. Dual-drug-loaded assisted topical delivery of photodynamically active lipid-based formulation for combination therapy of cutaneous melanoma. Mol Pharm. 2023;20(7):3653–71.
Article CAS PubMed Google Scholar
Swetha KL, Paul M, Maravajjala KS, Kumbham S, Biswas S, Roy A. Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle. J Control Release. 2023;356:93–114.
Article CAS PubMed Google Scholar
Patel T, Itoo AM, Paul M, Kondapaneni LP, Ghosh B, Biswas S. Block HPMA-based pH-sensitive gemcitabine pro-drug nanoaggregates for cancer treatment. Eur Polymer J. 2023;186:111843.
Kumbham S, Paul M, Itoo A, Ghosh B, Biswas S. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma. Int J Pharm. 2022;614:121479.
Article CAS PubMed Google Scholar
Pulya S, Patel T, Paul M, Adhikari N, Banerjee S, Routholla G, Biswas S, Jha T, Ghosh B. Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer. Eur J Med Chem. 2022;238:114470.
Article CAS PubMed Google Scholar
Pulya S, Himaja A, Paul M, Adhikari N, Banerjee S, Routholla G, Biswas S, Jha T, Ghosh B. Selective HDAC3 inhibitors with potent in vivo antitumor efficacy against triple-negative breast cancer. J Med Chem. 2023;66(17):12033–58.
留言 (0)